Pacific Biosciences of California, Inc. (PACB) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
PACB Q4 2025: Consumables Up 15% as HiFi Clinical Adoption Drives Margin Inflection
June 15, 2026
-
PACB Q1 2026: Clinical Consumables Up 100% as Academic Weakness Lowers Instrument Outlook
May 08, 2026
-
PACB Q3 2025: Consumables Hit 55% of Revenue, Driving Margin Recovery and Clinical Penetration
November 06, 2025
-
PACB Q2 2025: Vega Adds 40+ New Labs, Driving 53% APAC Growth and Expanding Clinical Adoption
August 08, 2025
-
PACB Q1 2025: Consumables Jump 26% as Long-Read Focus Drives Margin Expansion
July 05, 2025